Oculis SA

Swiss Biotech Association

Member

Oculis S.A. is a clinical-stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and lives of patients worldwide.

Products, services, technology

OCS-01 being developed in DME and Post-ocular surgery inflammation;
OCS-02 being developed for Dry Eye Disease and Uveitis;
Pre-clinical candidates for retinal disorders and for ocular inflammation

http://www.oculis.com
+41 21 711 39 70
louie-anne.gauthier@oculis.com
Louie-Anne Gauthier

Location

EPFL Innovation Park, 1015 Lausanne, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2017
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

TissueLabs Sagl

TissueLabs is the platform for creating organs and tissues in the lab. We offer biomaterials, equipment, and services to support tissue engineering and regenerative medicine. Our mission is to fabricate lab-grown tissues and organs, for both research and therapeutic applications.
Via Cantonale 18

Member

Limula SA

Limula SA is developing a platform technology to enable scale out of cell therapy manufacturing, directly at the point of care. We support companies at all stages of the life cycle of their therapies, from R&D to routine production.
La Tour-de-Peilz

Member

SIX

The Swiss Stock Exchange, representing more than a third of the European life sciences market capitalization and accounting for around 35% of the total market capitalization (as of 7 April 2021), the exchange is one of Europe’s leading listing venues for biotech companies.
Zürich

Not a member